Jonathan Rosenberg, MD
Interventional Cardiology · Evanston, ILNPI 1083900989
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (34.4%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Boston Scientific at 41.9% of the total. 2025 is the largest year on record at $25,346, 5.6 times the $4,488 reported in 2019. Among interventional cardiology clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 332 payments — averaging $174.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$24K
- Biosense Webster, Inc.$14K
- Abiomed$8K
- Abbott$2K
- Medtronic$2K
- Edwards Lifesciences$1K
- plus $7K from 29 others
Across 8 payments — averaging $499.98 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Edwards Lifesciences$3K
- Abiomed$645
What the payments were for
- Consulting fees$19,94234%
- Speaking & faculty fees$16,69229%
- Travel & lodging$9,27616%
- Food & beverage$12,00621%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 32 | $24,293 |
| Biosense Webster, Inc. | 17 | $14,153 |
| Abiomed | 54 | $7,522 |
| Abbott | 27 | $2,106 |
| Medtronic(2 entities) | 32 | $1,531 |
| Edwards Lifesciences | 12 | $1,309 |
| Shockwave Medical, Inc | 3 | $1,249 |
| Boehringer Ingelheim | 26 | $777 |
| Novartis | 24 | $567 |
| W. L. Gore & Associates, Inc. | 2 | $494 |
| ZOLL Medical Corporation | 3 | $493 |
| Pfizer | 16 | $424 |
| GE HealthCare | 1 | $337 |
| ZOLL Circulation Inc | 2 | $320 |
| Alnylam Pharmaceuticals Inc. | 11 | $261 |
| Johnson & Johnson | 9 | $224 |
| BD | 1 | $220 |
| Amgen | 5 | $191 |
| Chiesi USA, Inc. | 6 | $169 |
| Pentax Of America, Inc. | 3 | $148 |
| Asahi Intecc USA, Inc. | 2 | $132 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $123 |
| Opsens Inc. | 5 | $115 |
| Philips North America LLC | 3 | $103 |
| E.r. Squibb & Sons, L.L.C. | 5 | $102 |
| Heartflow, Inc. | 1 | $99 |
| Actelion Pharmaceuticals US, Inc. | 3 | $94 |
| Imperative Care, Inc | 4 | $86 |
| Bristol Myers Squibb | 4 | $63 |
| Cordis US CORP. | 3 | $61 |
| Teleflex LLC | 2 | $49 |
| AstraZeneca | 2 | $29 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $27 |
| Inari Medical, Inc. | 1 | $24 |
| Terumo Medical Corporation | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$13,750
- Impella$6,370
- GENERAL VASCULAR ACCESS$6,250
- AVVIGO Guidance System$5,413
- Watchman$1,369
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$1,100
- Mitra Clip system$993
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$588
- SAPIEN 3 Ultra RESILIA$463
- Product in Development$442
- GENERAL - THERAPIES$374
- GENERAL - STRUCTURAL HEART$349
- Defibrillator$340
- MUSE$337
- TherOx DS2 Console$320
- Catheter$320
- Downstream Cartridge$320
- AMPLATZER AMULET$181
- Vascular Lithotripsy$149
- COREVALVE EVOLUT R$143
How this compares
$57,915 in reported general payments places this provider in the 90th percentile of 303 interventional cardiology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 69 | $64,290 |
| JardianceEmpagliflozin | 44 | $61,377 |
| BrilintaTicagrelor | 45 | $32,807 |
| FarxigaDapagliflozin Propanediol | 17 | $15,483 |
| Prasugrel Hcl | 78 | $4,016 |
| ClopidogrelClopidogrel Bisulfate | 182 | $2,634 |
| Metoprolol Succinate | 110 | $1,947 |
| Atorvastatin Calcium | 172 | $1,879 |
| Rosuvastatin Calcium | 82 | $1,526 |
| Ezetimibe | 14 | $1,044 |
| Losartan Potassium | 47 | $452 |
| Carvedilol | 31 | $375 |
| Furosemide | 37 | $237 |
| Amlodipine Besylate | 40 | $224 |
| Ramipril | 28 | $199 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $424 | $64,29069 claims |
| Boehringer IngelheimJardiance | $777 | $61,37744 claims |
| AstraZenecaBrilinta, Farxiga | $29 | $48,29162 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 303 interventional cardiology providers in Illinois.
Other interventional cardiology in Evanston
- Mark RicciardiEvanston$253K
- Justin LevisayEvanston$106K
- Andrei PopElk Grove Village$900K
- Atman ShahChicago$788K
- Ravi RamanaPalos Park$458K
- Mahesh RajuDowners Grove$281K
- Neal SawlaniPark Ridge$246K
- Tony de MartiniSpringfield$208K
- Bouyella ReddyMoline$172K
- David StewartChicago$169K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.